Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
A.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
A.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
A.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
A.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
A.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.530EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.530EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.530ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.530ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.530EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.530EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.530ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.530ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.50EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.50ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.50ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.50EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.50EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.50ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.50ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.36EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.36ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.1.36ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.1.36EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1.36EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.36ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.23EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.23ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.23ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.23EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.23EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.38.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.38.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
XBB.1.38.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.38.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-15364Germany
XBB.1.38.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.38.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-8009.2China
XBB.1.38.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.38.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-15680China
N/AEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
N/AEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N/AECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
N/AECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used